APA (7th ed.) Citation

Satyam, S. M., Bairy, L. K., Rehman, A., Nair, A. A., Farook, M., Binu, N. N., . . . Khan, M. M. (2025). Dapagliflozin and Silymarin Ameliorate Cisplatin-Induced Nephrotoxicity via Nrf2/HO-1 Upregulation: A Preclinical Mechanistic Study. MDPI AG.

Chicago Style (17th ed.) Citation

Satyam, Shakta Mani, Laxminarayana Kurady Bairy, Abdul Rehman, Anuradha Asokan Nair, Mohamed Farook, Nirmal Nachiketh Binu, Sofiya Khan, Mohamed Yehya, and Mohammed Moin Khan. Dapagliflozin and Silymarin Ameliorate Cisplatin-Induced Nephrotoxicity via Nrf2/HO-1 Upregulation: A Preclinical Mechanistic Study. MDPI AG, 2025.

MLA (9th ed.) Citation

Satyam, Shakta Mani, et al. Dapagliflozin and Silymarin Ameliorate Cisplatin-Induced Nephrotoxicity via Nrf2/HO-1 Upregulation: A Preclinical Mechanistic Study. MDPI AG, 2025.